Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Sell
47
PBCRY Quote, Financials, Valuation and Earnings
Last price:
$14.66
Seasonality move
:
6.14%
Day range:
$14.44 - $15.15
52-week range:
$13.06 - $18.28
Dividend yield:
2.97%
P/E ratio:
21.42x
P/S ratio:
10.43x
P/B ratio:
4.28x
Volume:
50.4K
Avg. volume:
63.3K
1-year change:
-2.27%
Market cap:
$72.3B
Revenue:
$6.7B
EPS (TTM):
$0.68
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $5.2B | $5.3B | $5.6B | $6B | $6.7B | |
| Revenue Growth (YoY) | 13.71% | 2.65% | 5.46% | 8.08% | 10.89% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $738.5M | $628.9M | $679.8M | $765.2M | $830.2M | |
| Other Inc / (Exp) | $38.8M | $77.8M | $104.2M | -$70.8M | $100.8M | |
| Operating Expenses | $2.3B | $2.2B | $2.2B | $2.3B | $2.6B | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $2.6B | $2.3B | $2.7B | $3.4B | $3.9B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $545.2M | $442.9M | $515.3M | $654.1M | $756M | |
| Net Income to Company | -- | -- | -- | -- | -- | |
| Minority Interest in Earnings | -$347.6K | -$1.1M | -$1.2M | -$1.3M | -$1.2M | |
| Net Income to Common Excl Extra Items | $2B | $1.9B | $2.2B | $2.7B | $3.2B | |
| Basic EPS (Cont. Ops) | $0.41 | $0.38 | $0.44 | $0.56 | $0.65 | |
| Diluted EPS (Cont. Ops) | $0.41 | $0.38 | $0.44 | $0.56 | $0.65 | |
| Weighted Average Basic Share | $4.9B | $4.9B | $4.9B | $4.9B | $4.9B | |
| Weighted Average Diluted Share | $4.9B | $4.9B | $4.9B | $4.9B | $4.9B | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $3.4B | $3B | $3.2B | $3.8B | $4.6B | |
| Revenue (Reported) | $5.2B | $5.3B | $5.6B | $6B | $6.7B | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $3.4B | $3B | $3.2B | $3.8B | $4.6B | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $1.3B | $1.4B | $1.5B | $1.6B | $1.8B | |
| Revenue Growth (YoY) | -2.89% | 6.62% | 11.47% | 8.81% | 9.34% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $120.2M | $163.6M | $188M | $213.5M | $207.1M | |
| Other Inc / (Exp) | -$172.4M | $90.3M | $37.2M | $11.8M | $54.9M | |
| Operating Expenses | $436.9M | $542.1M | $596.9M | $636.5M | $622.8M | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $657.5M | $745.7M | $903.4M | $993.4M | $1.1B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $129M | $139.8M | $173.5M | $189.6M | $216.3M | |
| Net Income to Company | -- | -- | -- | -- | -- | |
| Minority Interest in Earnings | -$409.4K | -$350.5K | -$564.5K | -$651.7K | -$805.7K | |
| Net Income to Common Excl Extra Items | $528.1M | $605.6M | $729.4M | $803.1M | $899.9M | |
| Basic EPS (Cont. Ops) | $0.11 | $0.12 | $0.15 | $0.16 | $0.18 | |
| Diluted EPS (Cont. Ops) | $0.11 | $0.12 | $0.15 | $0.16 | $0.18 | |
| Weighted Average Basic Share | $4.9B | $4.9B | $4.9B | $4.9B | $4.9B | |
| Weighted Average Diluted Share | $4.9B | $4.9B | $4.9B | $4.9B | $4.9B | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $811.6M | $877.4M | $1B | $1.2B | $1.3B | |
| Revenue (Reported) | $1.3B | $1.4B | $1.5B | $1.6B | $1.8B | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $811.6M | $877.4M | $1B | $1.2B | $1.3B | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $5.4B | $5.4B | $5.9B | $6.5B | $6.9B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $684.1M | $641.9M | $736M | $794.4M | $820.1M | |
| Other Inc / (Exp) | -$31.7M | $200.2M | -$62.1M | $83.3M | $158.1M | |
| Operating Expenses | $2.2B | $2.1B | $2.3B | $2.5B | $2.6B | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $2.4B | $2.6B | $3.2B | $3.9B | $4.2B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $486.1M | $496.8M | $604M | $751.9M | $803.6M | |
| Net Income to Company | -- | -- | -- | -- | -- | |
| Minority Interest in Earnings | -$854.4K | -$1.3M | -$1.4M | -$1.6M | -$835.9K | |
| Net Income to Common Excl Extra Items | $1.9B | $2.1B | $2.5B | $3.2B | $3.4B | |
| Basic EPS (Cont. Ops) | $0.39 | $0.42 | $0.52 | $0.64 | $0.68 | |
| Diluted EPS (Cont. Ops) | $0.39 | $0.42 | $0.52 | $0.64 | $0.68 | |
| Weighted Average Basic Share | -- | -- | -- | -- | -- | |
| Weighted Average Diluted Share | -- | -- | -- | -- | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $3.1B | $3.1B | $3.6B | $4.5B | $4.8B | |
| Revenue (Reported) | $5.4B | $5.4B | $5.9B | $6.5B | $6.9B | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $3.1B | $3.1B | $3.6B | $4.5B | $4.8B | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $4B | $4.1B | $4.4B | $4.9B | $5.2B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $447.2M | $460.2M | $516.3M | $550.4M | $543M | |
| Other Inc / (Exp) | -$60M | $60.9M | -$104.4M | $54.3M | $112.7M | |
| Operating Expenses | $1.6B | $1.6B | $1.7B | $1.9B | $1.8B | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $1.7B | $2B | $2.4B | $3B | $3.2B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $322.3M | $377.5M | $466.3M | $567.2M | $614.7M | |
| Net Income to Company | -- | -- | -- | -- | -- | |
| Minority Interest in Earnings | -$676.6K | -$907K | -$1M | -$1.3M | -$885.1K | |
| Net Income to Common Excl Extra Items | $1.4B | $1.6B | $2B | $2.4B | $2.6B | |
| Basic EPS (Cont. Ops) | $0.28 | $0.33 | $0.40 | $0.49 | $0.52 | |
| Diluted EPS (Cont. Ops) | $0.28 | $0.33 | $0.40 | $0.49 | $0.52 | |
| Weighted Average Basic Share | $14.8B | $14.8B | $14.8B | $14.8B | $14.8B | |
| Weighted Average Diluted Share | $14.8B | $14.8B | $14.8B | $14.8B | $14.8B | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $2.2B | $2.4B | $2.7B | $3.4B | $3.7B | |
| Revenue (Reported) | $4B | $4.1B | $4.4B | $4.9B | $5.2B | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $2.2B | $2.4B | $2.7B | $3.4B | $3.7B | |
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $8.3B | $7.8B | $13.2B | $10.3B | $8.2B | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | $111.1M | $57.4M | $46.2M | $56.2M | $68.1M | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $10.2B | $19.5B | $24.8B | $21.3B | $15.8B | |
| Property Plant And Equipment | $1.5B | $1.5B | $1.6B | $1.6B | $1.7B | |
| Long-Term Investments | $10.7B | $13.7B | $15.9B | $16.1B | $20.9B | |
| Goodwill | $61.6M | $81.1M | $81.1M | $74.1M | $74.1M | |
| Other Intangibles | $37.6M | $33M | $29.7M | $26.2M | $26M | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $66.2B | $75.3B | $86B | $84.1B | $90.1B | |
| Accounts Payable | $236.3M | $303.6M | $329.5M | $192.3M | $408.2M | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $354.1M | $462.6M | $456.8M | $344.2M | $518.8M | |
| Long-Term Debt | -- | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $53.6B | $62.4B | $71.8B | $70B | $74.6B | |
| Common Stock | $110.9M | $107.9M | $107.9M | $98.6M | $98.6M | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | $12.5B | $12.9B | $14.2B | $14.1B | $15.5B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $7.2M | $8.3M | $9.5M | $10.4M | $11.6M | |
| Total Equity | $12.5B | $12.9B | $14.2B | $14.2B | $15.5B | |
| Total Liabilities and Equity | $66.2B | $75.3B | $86B | $84.1B | $90.1B | |
| Cash and Short Terms | $8.3B | $7.8B | $13.2B | $10.3B | $8.2B | |
| Total Debt | $300.9M | $190.3M | $160.2M | $134.8M | $151.8M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $6.6B | $12.4B | $10.3B | $9.1B | $7B | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | $56.5M | $50.2M | $59M | $58.1M | $105.4M | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $14.9B | $22.6B | $22.7B | $18.7B | $8.5B | |
| Property Plant And Equipment | $1.4B | $1.5B | $1.5B | $1.7B | $1.8B | |
| Long-Term Investments | $12.4B | $15.4B | $16.4B | $19.9B | $27B | |
| Goodwill | $77.6M | $79.9M | $76.4M | $75.3M | $76.4M | |
| Other Intangibles | $26.4M | $19.2M | $23M | $19.7M | $27.7M | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $67.2B | $80.7B | $85.1B | $89.8B | $94.6B | |
| Accounts Payable | $258.3M | $334.7M | $232M | $457.5M | $231M | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $389.2M | $470.1M | $360.8M | $517.9M | $316.2M | |
| Long-Term Debt | -- | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $55.2B | $67B | $71.1B | $74.5B | $77.7B | |
| Common Stock | $103.2M | $106.3M | $101.7M | $100.2M | $101.7M | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $7.4M | $9.1M | $9.9M | $11.8M | $12.9M | |
| Total Equity | $12B | $13.7B | $14B | $15.3B | $16.9B | |
| Total Liabilities and Equity | $67.2B | $80.7B | $85.1B | $89.8B | $94.6B | |
| Cash and Short Terms | $6.6B | $12.4B | $10.3B | $9.1B | $7B | |
| Total Debt | $166.4M | $140.2M | $144.7M | $111.5M | $151.1M | |
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -- | -- | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $3.7B | $3.5B | $8.8B | $2.3B | $3.8B | |
| Capital Expenditures | $189M | $184.4M | $230.1M | $226M | $334.6M | |
| Cash Acquisitions | -$65.3M | -$20.9M | -- | -- | -- | |
| Cash From Investing | -$2.5B | -$3B | -$2.9B | -$2.2B | -$4.6B | |
| Dividends Paid (Ex Special Dividend) | -$618.2M | -$940.3M | -$956.1M | -$1.3B | -$1.7B | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $6.4B | $2B | $503.2M | $1.6B | $3.3B | |
| Long-Term Debt Repaid | -$6.3B | -$2.1B | -$534M | -$1.6B | -$3.3B | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | $4.8M | -$9.3M | $5.4M | $11.2M | $52.8M | |
| Cash From Financing | -$518.1M | -$1.1B | -$981.5M | -$1.3B | -$1.6B | |
| Beginning Cash (CF) | $7.3B | $7.8B | $7.4B | $11.9B | $10.5B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $697.5M | -$599.5M | $4.9B | -$1.2B | -$2.4B | |
| Ending Cash (CF) | $8B | $7.3B | $12.3B | $10.8B | $8.2B | |
| Levered Free Cash Flow | $3.5B | $3.3B | $8.6B | $2B | $3.5B | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -- | -- | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$769.9M | $1.8B | -$3.9B | -$324.8M | $1.8B | |
| Capital Expenditures | $36.4M | $33.4M | $52.8M | $74.5M | $99.7M | |
| Cash Acquisitions | -$20.6M | -- | -- | -- | -- | |
| Cash From Investing | $844.8M | -$1B | -$1.1B | -$790.7M | -$2.5B | |
| Dividends Paid (Ex Special Dividend) | $17.9M | $31.9K | $24.9M | $32.8M | -$42.8M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -$646M | -$3.1B | $172.5M | $1.1B | $1.3B | |
| Long-Term Debt Repaid | $654.8M | $3.1B | -$161.3M | -$1.2B | -$1.3B | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | $1.8M | $14.6K | $15.4M | -$6.2M | $42.4M | |
| Cash From Financing | $28.5M | $25.6M | $51.4M | -$25.8M | -$43.6M | |
| Beginning Cash (CF) | $6.5B | $10.9B | $15.6B | $10.6B | $6.9B | |
| Foreign Exchange Rate Adjustment | $64.5M | -$1.5M | -$2.9M | -$21.9M | $110.7M | |
| Additions / Reductions | $103.3M | $830M | -$5B | -$1.1B | -$719.8M | |
| Ending Cash (CF) | $6.4B | $11.7B | $10.3B | $9.1B | $6.5B | |
| Levered Free Cash Flow | -$806.3M | $1.8B | -$3.9B | -$399.2M | $1.7B | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -- | -- | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $3.8B | $9.1B | $2.6B | $4.1B | $5.5B | |
| Capital Expenditures | $183.1M | $217.6M | $242.5M | $293.2M | $277.5M | |
| Cash Acquisitions | -$85.8M | -$372.9K | -- | -- | -- | |
| Cash From Investing | -$3.6B | -$3B | -$2.4B | -$3.4B | -$5.9B | |
| Dividends Paid (Ex Special Dividend) | -$933.6M | -$918.2M | -$1.2B | -$1.7B | -$2.1B | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $3.8B | $1.1B | $1.3B | $2.9B | $4.1B | |
| Long-Term Debt Repaid | -$3.8B | -$1.1B | -$1.3B | -$2.9B | -$4.1B | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$6.3M | -$220.4K | $13.4M | -$7.9M | $37.7M | |
| Cash From Financing | -$1B | -$957.2M | -$1.2B | -$1.7B | -$2.1B | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$777.1M | $5.2B | -$1B | -$1B | -$2.4B | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $3.6B | $8.9B | $2.3B | $3.8B | $5.2B | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -- | -- | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $1.8B | $7.4B | $1.2B | $3B | $4.7B | |
| Capital Expenditures | $94.8M | $128M | $140.4M | $207.6M | $150.5M | |
| Cash Acquisitions | -$20.6M | -- | -- | -- | -- | |
| Cash From Investing | -$2.4B | -$2.3B | -$1.8B | -$3B | -$4.3B | |
| Dividends Paid (Ex Special Dividend) | -$759.9M | -$737.8M | -$989.5M | -$1.4B | -$1.8B | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $1.1B | $188.3M | $966.5M | $2.3B | $3.2B | |
| Long-Term Debt Repaid | -$1.3B | -$235.4M | -$970.8M | -$2.3B | -$3.2B | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$6.1M | $3M | $11M | -$8M | -$23.1M | |
| Cash From Financing | -$897.3M | -$781.8M | -$982.8M | -$1.4B | -$1.8B | |
| Beginning Cash (CF) | $22.6B | $24.2B | $38.9B | $31.7B | $23.9B | |
| Foreign Exchange Rate Adjustment | $194M | $5.9M | $29.8M | $19.7M | $60.5M | |
| Additions / Reductions | -$1.4B | $4.4B | -$1.6B | -$1.4B | -$1.4B | |
| Ending Cash (CF) | $20.9B | $28.5B | $36.8B | $30.3B | $22.5B | |
| Levered Free Cash Flow | $1.7B | $7.3B | $1.1B | $2.8B | $4.6B | |
Get PBCRY Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
PBCRY
Sector
P/E ratio
21.42x
11.99x
PEG ratio
3.13x
0.36x
P/B ratio
4.28x
1.05x
Price / LTM sales
10.43x
2.55x
Growth Metrics
PBCRY
Sector
Revenue growth
9.34%
6.08%
Earnings growth
12.12%
6.45%
Revenue (5-year growth)
8.09%
5.85%
Earnings forecast
--
$0.56
Profitability
PBCRY
Sector
Profitability FY 2024
--
$179.9M
Return on invested capital
21.74%
5.27%
Return on assets
3.72%
0.98%
Return on equity
21.94%
9.43%
Earnings Date
Last Earnings Date
Dec
23
Next Earnings Date
Dec
23
Estimated Next Earnings Date
Mar
24
Balance Sheet
PBCRY
Sector
Total cash
$7B
$615.3M
Short term investments
--
$408.4M
Total assets
$90.1B
$4.5B
Long term debt
$151.1M
$270.8M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 21
Quantum [QMCO] is up 26.28% over the past day.
Sell
46
NUKK alert for Dec 21
Nukkleus [NUKK] is down 22.94% over the past day.
Sell
1
IIPR alert for Dec 21
Innovative Industrial Properties [IIPR] is down 22.7% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
